Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Aurora Zanghì, Emanuele D’Amico & Francesco Patti. (2020) Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment. Expert Review of Neurotherapeutics 20:8, pages 771-782.
Read now
Read now
Clara G. Chisari, Simona Toscano, Emanuele D’Amico, Salvatore Lo Fermo, Aurora Zanghì, Sebastiano Arena, Mario Zappia & Francesco Patti. (2019) An update on the safety of treating relapsing-remitting multiple sclerosis. Expert Opinion on Drug Safety 18:10, pages 925-948.
Read now
Read now
Emanuele D’Amico, Clara G Chisari, Lara Gitto, Aurora Zanghì, Simona Toscano & Francesco Patti. (2019) Pharmacoeconomics of synthetic therapies for multiple sclerosis. Expert Opinion on Pharmacotherapy 20:11, pages 1331-1340.
Read now
Read now
A. Zanghì & E. D’Amico. (2019) New treatment targets in multiple sclerosis therapy. Expert Review of Precision Medicine and Drug Development 4:4, pages 201-203.
Read now
Read now
E. D’Amico, F. Patti, A. Zanghì, S. Lo Fermo, C.G. Chisari & M. Zappia. (2018) Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience. Expert Review of Clinical Pharmacology 11:5, pages 531-536.
Read now
Read now
Michelle Ploughman. (2017) Breaking down the barriers to physical activity among people with multiple sclerosis – a narrative review. Physical Therapy Reviews 22:3-4, pages 124-132.
Read now
Read now
Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2017) Can new chemical therapies improve the management of multiple sclerosis in children?. Expert Opinion on Pharmacotherapy 18:1, pages 45-55.
Read now
Read now
Articles from other publishers (21)
Roya Abolfazli, Mohammad Ali Sahraian, Atefeh Tayebi, Hamidreza Kafi & Sara Samadzadeh. (2023) Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study. Journal of Clinical Medicine 12:15, pages 4937.
Crossref
Crossref
Michael Guger, Michael Matthias Ackerl, Martin Heine, Christiane Hofinger-Renner, Heinrich Karl Spiss, Andrea Taut, Karin Unger & Fritz Leutmezer. (2022) Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria. eNeurologicalSci 27, pages 100396.
Crossref
Crossref
Emanuele D'Amico, Aurora Zanghì & Carlo Avolio. (2022) Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies. Neural Regeneration Research 17:3, pages 567.
Crossref
Crossref
Efrat Neter, Lea Glass-Marmor, Anat Wolkowitz, Idit Lavi & Ariel Miller. (2021) Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis. BMC Neurology 21:1.
Crossref
Crossref
Aurora Zanghì, Carlo Avolio, Maria Pia Amato, Massimo Filippi, Maria Trojano, Francesco Patti & Emanuele D’Amico. (2021) First‐line therapies in late‐onset multiple sclerosis: An Italian registry study. European Journal of Neurology 28:12, pages 4117-4123.
Crossref
Crossref
Aurora Zanghì, Antonio Gallo, Carlo Avolio, Rocco Capuano, Matteo Lucchini, Maria Petracca, Simona Bonavita, Roberta Lanzillo, Diana Ferraro, Erica Curti, Maria Buccafusca, Graziella Callari, Stefania Barone, Giuseppe Pontillo, Gianmarco Abbadessa, Valeria Di Francescantonio, Elisabetta Signoriello, Giacomo Lus, Patrizia Sola, Franco Granella, Paola Valentino, Massimiliano Mirabella, Francesco Patti & Emanuele D’Amico. (2021) Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study. Neurotherapeutics 18:2, pages 1166-1174.
Crossref
Crossref
Emanuele D’Amico, Aurora Zanghì, Marzia Romeo, Eleonora Cocco, Giorgia Teresa Maniscalco, Vincenzo Brescia Morra, Damiano Paolicelli, Giovanna De Luca, Simonetta Galgani, Maria Pia Amato, Giuseppe Salemi, Matilde Inglese, Paolo Agostino Confalonieri, Giacomo Lus, Carlo Avolio, Antonio Gallo, Marika Vianello, Marco Onofrj, Massimo Filippi, Maria Trojano & Francesco Patti. (2021) Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register. Neurotherapeutics 18:2, pages 905-919.
Crossref
Crossref
Birgit Bauer, Bernd Brockmeier, Virginia Devonshire, Arthur Charbonne, Daniela Wach & Barry Hendin. (2020) An international discrete choice experiment assessing patients' preferences for disease-modifying therapy attributes in multiple sclerosis. Neurodegenerative Disease Management 10:6, pages 369-382.
Crossref
Crossref
Aurora Zanghì, Emanuele D'Amico, Maria Luca, Marco Ciaorella, Lucia Basile & Francesco Patti. (2020) Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience. Multiple Sclerosis and Related Disorders 46, pages 102561.
Crossref
Crossref
R. Lanzillo, M. Sparaco, L. Lavorgna, L. Carmisciano, E. Signoriello, A. Signori, T. Costabile, G. T. Maniscalco, F. Saccà, S. Cepparulo, C. V. Russo, A. Bisecco, N. Frattaruolo, A. Strianese, G. Lus, V. Brescia Morra & S. Bonavita. (2020) A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting. Neurological Sciences 41:11, pages 3235-3241.
Crossref
Crossref
Emanuele D’Amico, Aurora Zanghì, Mariangela Sciandra, Roberta Lanzillo, Graziella Callari, Antonio Cortese, Giacomo Lus, Matteo Lucchini, Maria Buccafusca, Simona Bonavita, Antonio Gallo, Erica Curti, Alberto Gajofatto, Elisabetta Signoriello, Alvino Bisecco, Francesca Gobbin, Maria Teresa Ferrò, Gina Ferrazzano, Maddalena Sparaco, Paola Valentino, Massimiliano Mirabella, Franco Granella, Vincenzo Bresciamorra, Luigi Maria Edoardo Grimaldi, Francesco Patti, Giovanna Borriello, Paola Grossi, Antonio Carotenuto, Ernesto Siena, Elena Tsantes, Alessia Giugno, Gian Marco Abbadessa & Clara Grazia Chisari. (2020) Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis. Journal of Neurology 267:10, pages 3008-3020.
Crossref
Crossref
Emanuele D'Amico, Aurora Zanghì, Giovanni Burgio, Clara Grazia Chisari, Rosita Angela Condorelli, Sandro La Vignera, Aldo Eugenio Calogero & Francesco Patti. (2020) Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study. Frontiers in Neurology 11.
Crossref
Crossref
Francesco Ferrara, Francesco De Rosa & Antonio Vitiello. (2020) Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?. SN Comprehensive Clinical Medicine 2:8, pages 1017-1018.
Crossref
Crossref
Aurora Zanghì, Emanuele D'Amico, Graziella Callari, Clara Grazia Chisari, Giovanna Borriello, Luigi Maria Edoardo Grimaldi & Francesco Patti. (2020) Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience. Frontiers in Neurology 11.
Crossref
Crossref
Emanuele D'Amico, Aurora Zanghì, Clara Grazia Chisari, Mario Zappia & Francesco Patti. (2019) Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study. Autoimmunity Reviews 18:10, pages 102365.
Crossref
Crossref
Francesco Saccà, Roberta Lanzillo, Alessio Signori, Giorgia T Maniscalco, Elisabetta Signoriello, Salvatore Lo Fermo, Annamaria Repice, Pietro Annovazzi, Damiano Baroncini, Marinella Clerico, Eleonora Binello, Raffaella Cerqua, Giorgia Mataluni, Simona Bonavita, Luigi Lavorgna, Ignazio Roberto Zarbo, Alice Laroni, Silvia Rossi, Lorena Pareja Gutierrez, Sara La Gioia, Barbara Frigeni, Valeria Barcella, Jessica Frau, Eleonora Cocco, Giuseppe Fenu, Valentina Torri Clerici, Arianna Sartori, Sarah Rasia, Cinzia Cordioli, Alessia Di Sapio, Simona Pontecorvo, Roberta Grasso, Caterina Barrilà, Cinzia Valeria Russo, Sabrina Esposito, Domenico Ippolito, Francesca Bovis, Fabio Gallo & Maria Pia Sormani. (2018) Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study. Multiple Sclerosis Journal 25:9, pages 1263-1272.
Crossref
Crossref
E. D’Amico, A. Zanghì, M. Sciandra, G. Borriello, G. Callari, A. Gallo, G. Salemi, S. Cottone, M. Buccafusca, P. Valentino, R. B. Bossio, L. M. E. Grimaldi, C. Pozzilli, G. Tedeschi, M. Zappia & F. Patti. (2018) Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience. Journal of Neurology 266:2, pages 411-416.
Crossref
Crossref
Emanuele D’Amico, Aurora Zanghì, Graziella Callari, Giovanna Borriello, Antonio Gallo, Giusi Graziano, Paola Valentino, Maria Buccafusca, Salvatore Cottone, Giuseppe Salemi, Paolo Ragonese, Roberto Bruno Bossio, Renato Docimo, Luigi Maria Edoardo Grimaldi, Carlo Pozzilli, Gioacchino Tedeschi, Mario Zappia & Francesco Patti. (2018) Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience. Therapeutic Advances in Neurological Disorders 11, pages 175628641879640.
Crossref
Crossref
Gustavo Saposnik, Angel Perez Sempere, Roula Raptis, Daniel Prefasi, Daniel Selchen & Jorge Maurino. (2016) Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS). BMC Neurology 16:1.
Crossref
Crossref
Vojtěch Thon. (2016) Immunological outlook on modern therapy of multiple sclerosis. Neurologie pro praxi 17:5, pages 310-314.
Crossref
Crossref
Emanuele D’Amico, Carmela Leone, Aurora Zanghì, Salvatore Lo Fermo & Francesco Patti. (2016) Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study. Journal of Neurology 263:9, pages 1802-1809.
Crossref
Crossref